Akademik Veri Yönetim Sistemi
Kocaeli Science Congress 2024 (KOSC-2024), Kocaeli, Türkiye, 2 - 04 Ekim 2024, ss.166-169
Medical radioactive copper isotopes represent a significant advancement in the diagnosis and treatment of cancer, as well as in neurological studies and other medical applications. They facilitate the early detection of diseases, thereby enabling the implementation of more efficacious treatment modalities. The 64Cu and 67Cu isotopes are frequently employed in this context. The medical applications of 64Cu are numerous, including cancer diagnosis, tumour tracking and monitoring of other biological events, examination of neurons and investigation of neurological diseases. It is also used for radiolabelling of biomolecules. 67Cu is employed in targeted radionuclide therapy due to its suitability as an isotope for radiation therapy. This study will investigate the production of medical copper using low energy accelerators.